Your browser doesn't support javascript.
loading
Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.
Lyu, Ning; Kong, Yanan; Mu, Luwen; Lin, Youen; Li, Jibin; Liu, Yaru; Zhang, Zhenfeng; Zheng, Lie; Deng, Haijing; Li, Shaolong; Xie, Qiankun; Guo, Rongping; Shi, Ming; Xu, Li; Cai, Xiuyu; Wu, Peihong; Zhao, Ming.
Afiliación
  • Lyu N; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Kong Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Mu L; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin Y; Department of Interventional Radiology, Jieyang Affiliated Hospital, Sun Yat-sen University, Jieyang, China.
  • Li J; Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Liu Y; Medical Imaging Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang Z; Medical Imaging Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zheng L; Medical Imaging Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Deng H; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li S; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xie Q; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Guo R; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Shi M; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu L; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai X; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu P; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhao M; Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address: zhaoming@sysucc.org.cn.
J Hepatol ; 69(1): 60-69, 2018 07.
Article en En | MEDLINE | ID: mdl-29471013

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucovorina / Carcinoma Hepatocelular / Fluorouracilo / Oxaliplatino / Sorafenib / Neoplasias Hepáticas / Estadificación de Neoplasias Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucovorina / Carcinoma Hepatocelular / Fluorouracilo / Oxaliplatino / Sorafenib / Neoplasias Hepáticas / Estadificación de Neoplasias Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China